Lantheus Holdings, Inc.

Symbol: LNTH

NASDAQ

58.87

USD

Market price today

  • 11.3318

    P/E Ratio

  • 0.1643

    PEG Ratio

  • 4.03B

    MRK Cap

  • 0.00%

    DIV Yield

Lantheus Holdings, Inc. (LNTH) Stock Price & Analysis

Shares Outstanding

69.31M

Gross Profit Margin

0.65%

Operating Profit Margin

0.35%

Net Profit Margin

0.34%

Return on Assets

0.25%

Return on Equity

0.61%

Return on Capital Employed

0.30%

Company general description and statistics

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
CEO:Mr. Brian A. Markison
Full-time employees:834
City:North Billerica
Address:331 Treble Cove Road
IPO:2015-06-25
CIK:0001521036

Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for nuclear medicine; Xenon-133 to assess pulmonary function; Neurolite to identify the area within the brain where blood flow has been blocked or reduced due to stroke; Cardiolite, an injectable Tc-99m-labeled imaging agent; Thallium-201 to detect cardiovascular disease; and Gallium-67 to detect various infections and cancerous tumors. The company also offers AZEDRA, a radiotherapeutic to treat adult and pediatric patients; Automated Bone Scan Index that calculates the disease burden of prostate cancer by quantifying the hotspots on bone scans; and Cobalt (Co 57), a non-pharmaceutical radiochemical; RELISTOR for opioid-induced constipation; and PYLARIFY for visualization of lymph nodes, bone, and soft tissue metastases to determine the presence or absence of recurrent and/or metastatic prostate cancer. It also develops flurpiridaz F 18 to assess blood flow to the heart; 1095, a PSMA-targeted iodine-131 labeled small molecule; LMI 1195 for neuroblastoma tumors in pediatric and adults; PYLARIFY AI, an AI-based medical device software to perform standardized quantitative assessment of PSMA PET/CT images in prostate cancer; and leronlimab, an investigational humanized monoclonal antibody. The company serves radio pharmacies, distributors, integrated delivery networks, hospitals, clinics, and group practices. It has strategic partnerships with NanoMab Technology Limited; Bausch Health Companies, Inc.; GE Healthcare Limited; Curium; Bayer AG; CytoDyn Inc.; ROTOP; FUJIFILM; Regeneron Pharmaceuticals, Inc.; and POINT Biopharma US Inc. The company was founded in 1956 and is headquartered in North Billerica, Massachusetts.

General Outlook

In simple terms, Lantheus Holdings, Inc. has 69.313 M shares that people are buying and selling right now. When we look at how much money they make before expenses, they keep 0.648% as profit. This shows they're good at controlling costs and are financially stable. Their operating profit, which is money made from regular business activities, is 0.347%. This means they run their business efficiently. Lastly, after paying all their bills, they still have a profit of 0.337%. This tells us they're good at keeping money after all costs.

Return on Investments

The company's asset efficiency, represented by a robust 0.251% return, is a testament to Lantheus Holdings, Inc.'s adeptness in optimizing resource deployment. Lantheus Holdings, Inc.'s utilization of its assets to generate profits is strikingly evident through a noteworthy return on equity of 0.611%. Furthermore, the proficiency of Lantheus Holdings, Inc. in capital utilization is underscored by a remarkable 0.298% return on capital employed.

Stock Prices

Lantheus Holdings, Inc.'s stock prices have been subject to undulating patterns. The peak stock value during this interval surged to $69.02, while its low point bottomed out at $65.89. This variance in figures offers investors a lucid insight into the roller-coaster ride that is Lantheus Holdings, Inc.'s stock market.

Liquidity Ratios

Analyzing LNTH liquidity ratios reveals its financial health of the firm. The current ratio of 484.32% gauges short-term asset coverage for liabilities. The quick ratio (445.06%) assesses immediate liquidity, while the cash ratio (302.82%) indicates cash reserves.

cards.indicatorcards.value
Current Ratio484.32%
Quick Ratio445.06%
Cash Ratio302.82%

Profitability Ratios

LNTH profitability indicators offer a lens into its earnings landscape. A pretax profit margin of 43.45% underscores its earnings before tax deductions. The effective tax rate stands at 22.38%, revealing its tax efficiency. The net income per EBT, 77.62%, and the EBT per EBIT, 125.08%, provide insights into its earnings hierarchy. Lastly, with an EBIT per revenue ratio of 34.74%, we grasp its operational profitability.

cards.indicatorcards.value
Pretax Profit Margin43.45%
Effective Tax Rate22.38%
Net Income per EBT77.62%
EBT per EBIT125.08%
EBIT per Revenue34.74%

Operational Efficiency

Operational metrics shed light on its business agility. With an operating cycle of 4.84, it details the span from stock purchase to revenue. The 4 days it takes to settle debts showcases its creditor relations. Meanwhile, a 3 cash conversion cycle and 404.76% receivables turnover rate reflect its cash flow efficiency and credit management, respectively.

cards.indicatorcards.value
Days of Sales Outstanding445
Days of Inventory Outstanding53
Operating Cycle143.07
Days of Payables Outstanding28
Cash Conversion Cycle115
Receivables Turnover4.05
Payables Turnover12.83
Inventory Turnover6.90
Fixed Asset Turnover9.10
Asset Turnover0.75

Cash Flow Ratios

Peering into the cash flow metrics reveals liquidity and operational efficiency. The operating cash flow per share, 4.71, and free cash flow per share, 4.05, depict cash generation on a per-share basis. The cash per share value, 10.45, showcases liquidity position. Lastly, the operating cash flow sales ratio, 0.24, offers insight into cash flow relative to sales.

cards.indicatorcards.value
Operating Cash Flow per Share4.71
Free Cash Flow per Share4.05
Cash per Share10.45
Operating Cash Flow Sales Ratio0.24
Free Cash Flow to Operating Cash Flow Ratio0.86
Cash Flow Coverage Ratio0.58
Short Term Coverage Ratio441.41
Capital Expenditure Coverage Ratio7.10
Dividend Paid and Capex Coverage Ratio7.10

Debt and Leverage Ratios

Diving into debt and leverage metrics unveils the company's financial structure. The debt ratio, at 30.75%, highlights its total liabilities relative to assets. With a debt-equity ratio of 0.60, we discern the balance between debt and equity financing. The long-term debt to capitalization, 37.30%, and total debt to capitalization, 37.33%, ratios shed light on its capital structure. An interest coverage of 23.85 indicates its ability to manage interest expenses.

cards.indicatorcards.value
Debt Ratio30.75%
Debt Equity Ratio0.60
Long Term Debt to Capitalization37.30%
Total Debt to Capitalization37.33%
Interest Coverage23.85
Cash Flow to Debt Ratio0.58
Company Equity Multiplier1.94

Per Share Data

Speaking about the per share data offers a perceptive view of financial distribution. The revenue per share, 18.99, provides a glimpse into top-line earnings distributed across each share. Net income per share, 4.79, reflects the portion of profit attributed to each share. The book value per share, 11.95, represents the net asset value distributed per share, while the tangible book value per share, 8.83, excludes intangible assets.

cards.indicatorcards.value
Revenue Per Share18.99
Net Income Per Share4.79
Book Value Per Share11.95
Tangible Book Value Per Share8.83
Shareholders Equity Per Share11.95
Interest Debt Per Share9.33
Capex Per Share-0.68

Growth Ratios

Delving into growth metrics provides a snapshot of financial expansion. The revenue growth rate, 38.65%, indicates top-line expansion, while the gross profit growth, 21.98%, reveals profitability trends. EBIT growth, 2813.72%, and operating income growth, 2813.72%, offer insights into operational profitability progression. The net income growth, 1063.86%, showcases bottom-line expansion, and the EPS growth, 1068.29%, measures the growth in earnings per share.

cards.indicatorcards.value
Revenue Growth38.65%
Gross Profit Growth21.98%
EBIT Growth2813.72%
Operating Income Growth2813.72%
Net Income Growth1063.86%
EPS Growth1068.29%
EPS Diluted Growth1062.50%
Weighted Average Shares Growth-0.32%
Weighted Average Shares Diluted Growth-0.61%
Operating Cash Flow Growth8.33%
Free Cash Flow Growth-1.80%
10-Year Revenue Growth per Share21.05%
5-Year Revenue Growth per Share111.45%
3-Year Revenue Growth per Share202.89%
10-Year Operating CF Growth per Share619.21%
5-Year Operating CF Growth per Share179.38%
3-Year Operating CF Growth per Share1376.38%
10-Year Net Income Growth per Share240.56%
5-Year Net Income Growth per Share351.53%
3-Year Net Income Growth per Share2022.64%
10-Year Shareholders Equity Growth per Share191.75%
5-Year Shareholders Equity Growth per Share543.57%
3-Year Shareholders Equity Growth per Share25.82%
10-Year Dividend per Share Growth per Share-100.00%
Receivables Growth33.22%
Inventory Growth80.49%
Asset Growth24.97%
Book Value per Share Growth83.06%
Debt Growth10.55%
R&D Expense Growth-75.07%
SGA Expenses Growth14.27%

Other Metrics

Venturing into other key metrics unveils diverse facets of financial performance. The enterprise value, 4,135,782,000, captures the company's total value, considering both debt and equity. Income quality, 0.93, assesses the reliability of reported earnings. The sales, general, and administrative to revenue ratio, 0.10, gauges operational efficiency, while the research and development to revenue, 5.99%, highlights investment in innovation. The ratio of intangibles to total assets, 12.91%, indicates the value of non-physical assets, and capex to operating cash flow, -15.25%, measures reinvestment capability.

cards.indicatorcards.value
Enterprise Value4,135,782,000
Income Quality0.93
Sales General and Administrative to Revenue0.10
Research and Development to Revenue5.99%
Intangibles to Total Assets12.91%
Capex to Operating Cash Flow-15.25%
Capex to Revenue-3.59%
Capex to Depreciation-77.54%
Stock-Based Compensation to Revenue3.90%
Graham Number35.87
Return on Tangible Assets22.72%
Graham Net Net1.81
Working Capital898,469,000
Tangible Asset Value602,718,000
Net Current Asset Value250,562,000
Invested Capital1
Average Receivables248,844,500
Average Payables30,876,000
Average Inventory49,752,000
Days Sales Outstanding80
Days Payables Outstanding26
Days of Inventory On Hand40
ROIC20.23%
ROE0.40%

Valuation Ratios

Exploring the valuation ratios offers insights into perceived market value. The price to book value ratio, 5.52, and the price to book ratio, 5.52, reflect the market's valuation relative to the company's book value. The price to sales ratio, 3.85, provides a perspective on valuation in relation to sales. Ratios like price to free cash flows, 18.90, and price to operating cash flows, 16.11, gauge market valuation against cash flow metrics.

cards.indicatorcards.value
Price Book Value Ratio5.52
Price to Book Ratio5.52
Price to Sales Ratio3.85
Price Cash Flow Ratio16.11
Price Earnings to Growth Ratio0.16
Enterprise Value Multiple9.67
Price Fair Value5.52
Price to Operating Cash Flow Ratio16.11
Price to Free Cash Flows Ratio18.90
Price to Tangible Book Ratio5.19
Enterprise Value to Sales3.19
Enterprise Value Over EBITDA9.31
EV to Operating Cash Flow13.55
Earnings Yield7.72%
Free Cash Flow Yield6.11%
security
Trusted project
“All information displayed on the site is verified. High quality project and financial performance”
Eugene Alexeev
NumFin Founder and investing enthusiast

Frequently Asked Question

How many company shares are outstanding in 2024?

There are stock number shares outstanding of Lantheus Holdings, Inc. (LNTH) on the NASDAQ in 2024.

What is P/E ratio of enterprise in 2024?

The current P/E ratio of enterprise is 11.332 in 2024.

What is the ticker symbol of Lantheus Holdings, Inc. stock?

The ticker symbol of Lantheus Holdings, Inc. stock is LNTH.

What is company IPO date?

IPO date of Lantheus Holdings, Inc. is 2015-06-25.

What is company current share price?

Current share price is 58.870 USD.

What is stock market cap today?

The market cap of stock today is 4034102072.000.

What is PEG ratio in 2024?

The current 0.164 is 0.164 in 2024.

What is the number of employees in 2024?

In 2024 the company has 834.